Carlos Paya, M.D., Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Carlos Paya, M.D., Ph.D.
Earlier roles on record: Board Member at Standard Biotools Inc. (LAB) until January 5, 2024. Standard Biotools Inc. reported in an 8-K filed January 5, 2024 that Carlos Paya, M.D., Ph.D. resigned as director, effective January 5, 2024.
“On January 5, 2024, in connection with the consummation of the Merger and pursuant to the Merger Agreement, Carlos Paya, M.D., Ph.D., Laura Clague and Martin Madaus, Ph.D. resigned from Standard BioTools' board of directors (the "Standard BioTools Board") and ceased serving on the Standard BioTools Board and any and all committees thereof.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2021-05-25–2024-01-05
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.